St. Louis, MO (PRWEB) September 27, 2012
Earlier this year True-Dose staff members arranged a meeting with the Chain Drug Consortium (CDC) VP of Purchasing, Lou Helfrich. True-Dose’s goal of this meeting was to communicate the value of their products for CDC members. Now True-Dose will be partnering with CDC to distribute their pet supplements throughout CDC pharmacies. The Chain Drug Consortium is comprised of over 1,500 multi-unit independent pharmacies across the country. CDC's goal is to provide their member stores with pre-selected staple items that could work in any of their stores. In a market flooded with products, CDC makes new product selections painless for their members.
Soon CDC will launch a full pet program packed with carefully selected pet products ranging from nutritional supplements to shampoos. True-Dose’s pet supplements, including their popular Calming supplement, will be among these products. True-Dose owner, Joe Wayman, stated, "True-Dose is excited to partner with CDC. Customers expect higher quality from their pharmacy, and True-Dose allows the pharmacy to offer human grade products for pets that really do work.”
With the rapid growth of the pet industry, adding more products for pets is a great fit for many pharmacies, making it easy for pet parents to take care of personal and pet needs all in one place. True-Dose products are ideal pharmacies because of their proven absorption, pharmaceutical delivery, and high quality ingredients. This new partnership will allow more people than ever to experience the benefits of True-Dose pet supplements.
True-Dose uses patented technology to provide your pet with a higher level of quality in nutritional and functional supplements. Our supplements are manufactured in a human pharmaceutical facility, following the same strict testing and quality standards mandated by the FDA for state of the art pharmaceutical product manufacturing. True-Dose is an industry leader in maintaining standards to ensure the quality and safety your dog & cat deserve.
Chain Drug Consortium
Chain Drug Consortium provides its retail members an innovative savings approach through key purchasing programs and services, which help maximize market opportunities. Their focus is directed towards grouping together and increasing their member’s volume and buying power to allow the retail members to compete with the mega-chains. The Chain Drug Consortium is punctuated with innovation and leadership in a family environment.